Email Print this page Bookmark this page

Treatments for Dry Eye

Unfortunately, there is no cure for Dry Eye.1 However, once you have successfully diagnosed your patient with Dry Eye, there are several treatment options that you can suggest.

Some treatments, like artificial tear products, will work in mild cases of Dry Eye that do not require repeated applications throughout the day.2 However, for your moderate to severe patients who need continuous, all-day relief, preservative-free, prescription LACRISERT® may be best.2,3

Click the following links to learn more about Dry Eye treatments:

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

References: 1. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):163-178. Available at: http://www.tearfilm.org/dewsreport. Accessed January 5, 2009. 2. Katz JI, Kaufman HE, Breslin C, Katz IM. Slow-release artificial tears and the treatment of keratitis sicca. Ophthalmology. 1978;85(8):787-793. 3. Lacrisert [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2007.

sample request using Lacrisert video patient tip sheet
© 2011 ATON Pharma, a Division of Valeant Pharmaceuticals North America LLC. All Rights Reserved.